About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Biomarker Study of Pancreatic Neuroendocrine Tumours

NCT03741517·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Joakim Crona, MD, PhD
CONTACT
0046186110000 joakim.crona@medsci.uu.se

Lead

Uppsala University

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Age ≥18 years
Informed consent
Pathology confirmed diagnosis of pancreatic neuroendocrine tumor WHO grade 1-3 or neuroendocrine carcinoma grade 3.

You may not be if

Patient does not consent
Pregnancy or no contraceptive in fertile women.

The record

StatusUnknown

PhaseNo phase

Taking part40

StartedJan 2019

UpdatedMay 18, 2022

Conditions

Pancreatic Neuroendocrine Tumor

Where1

Akademiska Sjukhuset
Uppsala, Sweden

Clareo Health | Biomarker Study of Pancreatic Neuroendocrine Tumours